BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05328102-completion@plaintrial.com
DTSTAMP:20261027T171254Z
DTSTART;VALUE=DATE:20230221
SUMMARY:Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalido
 mide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) 
 Diffuse Large-cell B-cell Lymphoma (DLBCL) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05328102
URL:https://plaintrial.com/trial/NCT05328102
END:VEVENT
END:VCALENDAR